Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by qwerty22on Jul 09, 2022 8:47am
226 Views
Post# 34812664

RE:Now this could be interesting!

RE:Now this could be interesting!

I'm thinking of calling this BS.

I'm pretty sure we'd know if there had been a Trogarzo/coronavirus study. I can't find evidence of one. She isn't privy to some secret database of data. Best I can come up with is she's mixed up Trogarzo with CYDY's antibody which has been extensively studied against Covid (with meh results). CYDY's antibody isn't on her list.

The fact the second half of the tweet is a quasi-conspitorial suggestion that Pfizer are pulling the strings at the FDA suggest the clinical facts aren't necessarily the priority with this tweet.


SPCEO1 wrote: Saw this on Twitter:
 

A few antivirals available by prescription when given early that can help prevent/lessen viral illness: Valtrex, Tamiflu,Trogarzo,Lagevrio. Yet, the FDA is allowing Paxlovid, one of the least studied antivirals, be given without an Rx. Pfizer must have a friend at the FDA.
 
 



<< Previous
Bullboard Posts
Next >>